Fol. Biol. 2024, 70, 95-103
https://doi.org/10.14712/fb2024070020095
miR-325 Supresses Cell Proliferation and Migration in Non-Small Cell Lung Cancer via Targeting DNA Ligase 1 (LIG1)
References
1. , V., Bell, G. W., Nam, J.-W. et al. (2015) Predicting effective microRNA target sites in mammalian mRNAs. Elife 4, e05005.
<https://doi.org/10.7554/eLife.05005>
2. , J. F., Nana-Sinkam, S. P. (2015) MicroRNA as tools and therapeutics in lung cancer. Respir. Med. 109, 803-812.
<https://doi.org/10.1016/j.rmed.2015.02.006>
3. , R., Pulliero, A., Bulgakova, O. et al. (2020) Radon biomonitoring and microRNA in lung cancer. Int. J. Mol. Sci. 21, 2154.
<https://doi.org/10.3390/ijms21062154>
4. , A. T., Barnett, R. E., Druen, D. et al. (2012) MicroRNA as a new factor in lung and esophageal cancer. Semin. Thorac. Cardiovasc. Surg. 24, 155-165.
<https://doi.org/10.1053/j.semtcvs.2012.06.009>
5. , X., Zhong, S., Zhu, X. et al. (2008) Rational design of human DNA ligase inhibitors that target cellular DNA replication and repair. Cancer Res. 68, 3169-3177.
<https://doi.org/10.1158/0008-5472.CAN-07-6636>
6. , H., Lin, L., Hu, N. et al. (2019) KIF2C exerts an oncogenic role in nonsmall cell lung cancer and is negatively regulated by miR‐325‐3p. Cell Biochem. Funct. 37, 424-431.
<https://doi.org/10.1002/cbf.3420>
7. , R., Heymach, J., Lippman, S. (2008) Lung cancer. N. Engl. J. Med. 359, 1367-1380.
<https://doi.org/10.1056/NEJMra0802714>
8. , T. R., Sallmyr, A., Brooks, R. et al. (2017) Structure-activity relationships among DNA ligase inhibitors: characterization of a selective uncompetitive DNA ligase I inhibitor. DNA Repair (Amst.) 60, 29-39.
<https://doi.org/10.1016/j.dnarep.2017.10.002>
9. , Z., Luo, Y., Chen, C. et al. (2023) miR-325-3p reduces proliferation and promotes apoptosis of gastric cancer cells by inhibiting human antigen R. Can. J. Gastroenterol. Hepatol. 2023, 6882851.
10. , A., O’Donnell, M. (2005) DNA ligase: getting a grip to seal the deal. Curr. Biol. 15, R90-R92.
<https://doi.org/10.1016/j.cub.2005.01.025>
11. , D., Li, R., Zhang, J. et al. (2015) Association between the LIG1 polymorphisms and lung cancer risk: a meta-analysis of case-control studies. Cell Biochem. Biophys. 73, 381-387.
<https://doi.org/10.1007/s12013-015-0619-3>
12. , G., Duan, J., Shu, S. et al. (2016) Ligase I and ligase III mediate the DNA double-strand break ligation in alternative end-joining. Proc. Natl. Acad. Sci. U. S. A. 113, 1256-1260.
<https://doi.org/10.1073/pnas.1521597113>
13. , E., Ezponda, T., Bértolo, C. et al. (2018) The oncogenic RNA-binding protein SRSF1 regulates LIG1 in non-small cell lung cancer. Lab. Invest. 98, 1562-1574.
<https://doi.org/10.1038/s41374-018-0128-2>
14. , J. R., Yang, P., Cassivi, S. D. et al. (2008) Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin. Proc. 83, 584-594.
<https://doi.org/10.1016/S0025-6196(11)60735-0>
15. , D., Ng, S. H., Gao, F. et al. (2010) Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey. J. Thorac. Oncol. 5, 29-33.
<https://doi.org/10.1097/JTO.0b013e3181c5920c>
16. , L., Li, Q. K. (2017) Biomarkers in the accurate subclassification of non-small-cell lung carcinoma for targeted therapy: issues and prospects. Biomark. Med. 11, 405-407.
<https://doi.org/10.2217/bmm-2017-0059>
17. , P., Brambilla, E., Thomas, R. et al. (2012) Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities. Clin. Cancer Res. 18, 2443-2451.
<https://doi.org/10.1158/1078-0432.CCR-11-2370>
18. , Y., Song, Z., Rieser, J. et al. (2023) USP15 represses hepatocellular carcinoma progression by regulation of pathways of cell proliferation and cell migration: a system biology analysis. Cancers (Basel) 15, 1371.
<https://doi.org/10.3390/cancers15051371>
19. , R., Slack, F. J. (2017) MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat. Rev. Drug Discov. 16, 203-222.
<https://doi.org/10.1038/nrd.2016.246>
20. , C. A., Rasband, W. S., Eliceiri, K. W. (2012) NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671-675.
<https://doi.org/10.1038/nmeth.2089>
21. , R. L., Miller, K. D., Fuchs, H. E. et al. (2021) Cancer statistics, 2021. CA Cancer J. Clin. 71, 7-33.
<https://doi.org/10.3322/caac.21654>
22. , D., Urrabaz, R., Nguyen, M. et al. (2001) Elevated expression of DNA ligase I in human cancers. Clin. Cancer Res. 7, 4143-4148.
23. , S., Liu, F., Xian, S. et al. (2020) miR-325-3p overexpression inhibits proliferation and metastasis of bladder cancer cells by regulating MT3. Med. Sci. Monit. 26, e920331-1.
24. , Z., Li, C., Kang, B. et al. (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45, W98-W102.
<https://doi.org/10.1093/nar/gkx247>
25. , H., He, X., Yin, L. et al. (2015) Relationship between genetic polymorphisms of DNA ligase 1 and non-small cell lung cancer susceptibility and radiosensitivity. Genet. Mol. Res. 14, 7047-7052.
<https://doi.org/10.4238/2015.June.26.14>
26. , D. J., Singleton, M. R., Wigley, D. B. (2000) DNA ligases in the repair and replication of DNA. Mutat. Res. 460, 301-318.
<https://doi.org/10.1016/S0921-8777(00)00033-1>
27. , L. A., Bray, F., Siegel, R. L. et al. (2015) Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87-108.
<https://doi.org/10.3322/caac.21262>
28. , Q., Su, H. (2021) MiR-325-3p functions as a suppressor miRNA and inhibits the proliferation and metastasis of glioma through targeting FOXM1. J. Integr. Neurosci. 20, 1019-1028.
<https://doi.org/10.31083/j.jin2004103>
29. , S., Zhao, T., Jin, H. (2015) Expression of MicroRNA-325-3p and its potential functions by targeting HMGB1 in non-small cell lung cancer. Biomed. Pharmacother. 70, 72-79.
<https://doi.org/10.1016/j.biopha.2015.01.013>
